The evidence showing that E2 causes an imbalance in sGC subunit expression8–10 and that sGCα1 levels directly correlate with E2-induced cell proliferation11 led us to investigate sGCα1 as a potential factor mediating E2 pro-tumoural effects in an endometrial cancer cell line. Here, SGCB is linked to endometrial cancer.